The Tus Science & Technology Service Group, an enterprise group in China, led the Series A round with participation from the commercialization arm of University of Pittsburgh Medical Center — UPMC Enterprises.
The researchers’ software program, VISYTER, is only available for research purposes, but has been licensed to a Pittsburgh company for commercialization, according to Andi Saptono, assistant professor of health and rehabilitation informatics at University of Pittsburgh.
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Alzheimer's diease could potentially be detected with saliva samples, the University of Pittsburgh’s Vascular Medicine Institute receives $20M.
In an attempt to better manage the seeming deluge of big data in healthcare, the University of Pittsburgh Medical Center, the University of Pittsburgh and Carnegie Mellon University have teamed up to form the Pittsburgh Health Data Alliance. The three academic organizations aim to integrate more seamlessly data from EHRs, diagnostic imaging, genomic profiles, insurance […]
Healthcare for men and women has many overlaps, but some new research has indicated that we actually differ in the way cigarettes could affect us, which could also result in gender-specific cessation programs. Researchers, who published a study earlier this month in the Journal of Neuroscience by author Kelly Cosgrove, Ph.D., of Yale University used PET […]
For a whopping $48 million, the first government mass media campaign to convince cigarette smokers to quit sounds pretty pricey, but what does that number really mean in terms of the cost for each smoker who quits? The money only purchased three months of television ads from March through June of 2o12. But that was enough […]
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.
Cleveland biotech company Western Oncolytics is developing an immune-oncolytic therapy licensed by the University of Pittsburgh which combines oncolytic virus and gene therapy technologies to rid cancer cells of the ability to survive in the body. According to their website, the company expects their technology to extend the lives of, or even cure, patients with an array of […]
With a little genetic engineering, the vaccine that was key in helping eradicate smallpox more than 30 years ago could also be key in curing cancer, if a young Cleveland biotech has anything to say about it. Western Oncolytics is developing a dual-mechanism therapy that combines oncolytic virus and gene therapy technologies with the hope […]